Corporate Social Responsibility Report

The report describes Illumina's 2020 progress in expanding access to genomics, including a $20 million commitment to launch the Africa Pathogen Genomics Initiative and continued patient support. It reports environmental progress through renewable-energy initiatives, a 30% Scope 1 and 2 reduction target for 2030, and 36,573 MT CO2e of current Scope 1 and 2 emissions. The report also covers a global workforce of 7,828 employees, diversity and pay-equity efforts, employee support during COVID-19, and Board-level CSR oversight.